Masaki Otagiri
Researcher Next ID · RN-041718
Researcher · Biochemistry, Genetics and Molecular Biology
Kumamoto, Czechia
- Works count
- 724
- Citation count
- 22,737
- H-index
- 64
- i10-index
- 429
Research interests
Publications
Antioxidant activities of chitosans and its derivatives in in vitro and in vivo studies
Carbohydrate Polymers · 2018 · 10.1016/j.carbpol.2018.07.016
Antioxidant activities of chitosans and its derivatives in in vitro and in vivo studies
Carbohydrate Polymers · 2018 · 10.1016/j.carbpol.2018.07.016
Potential therapeutic interventions for chronic kidney disease‐associated sarcopenia via indoxyl sulfate‐induced mitochondrial dysfunction
Journal of Cachexia Sarcopenia and Muscle · 2017 · 10.1002/jcsm.12202
Potential therapeutic interventions for chronic kidney disease‐associated sarcopenia via indoxyl sulfate‐induced mitochondrial dysfunction
Journal of Cachexia Sarcopenia and Muscle · 2017 · 10.1002/jcsm.12202
Indoxyl sulfate potentiates skeletal muscle atrophy by inducing the oxidative stress-mediated expression of myostatin and atrogin-1
Scientific Reports · 2016 · https://doi.org/10.1038/srep32084
Cys34-Cysteinylated Human Serum Albumin Is a Sensitive Plasma Marker in Oxidative Stress-Related Chronic Diseases
PLoS ONE · 2014 · 10.1371/journal.pone.0085216
Albumin–drug interaction and its clinical implication
Biochimica et Biophysica Acta (BBA) - General Subjects · 2013 · https://doi.org/10.1016/j.bbagen.2013.05.005
p -Cresyl sulfate causes renal tubular cell damage by inducing oxidative stress by activation of NADPH oxidase
Kidney International · 2013 · https://doi.org/10.1038/ki.2012.448
Redox properties of serum albumin
Biochimica et Biophysica Acta (BBA) - General Subjects · 2013 · 10.1016/j.bbagen.2013.04.036
Antioxidant properties of some different molecular weight chitosans
Carbohydrate Research · 2009 · 10.1016/j.carres.2009.05.006
Antioxidant properties of some different molecular weight chitosans
Carbohydrate Research · 2009 · 10.1016/j.carres.2009.05.006
Structural Basis of the Drug-binding Specificity of Human Serum Albumin
Journal of Molecular Biology · 2005 · https://doi.org/10.1016/j.jmb.2005.07.075
A Molecular Functional Study on the Interactions of Drugs with Plasma Proteins
Drug Metabolism and Pharmacokinetics · 2005 · 10.2133/dmpk.20.309
The effect of glycation on the structure, function and biological fate of human serum albumin as revealed by recombinant mutants
Biochimica et Biophysica Acta (BBA) - General Subjects · 2003 · 10.1016/j.bbagen.2003.08.001
Characterization of uremic toxin transport by organic anion transporters in the kidney
Kidney International · 2003 · https://doi.org/10.1111/j.1523-1755.2004.00354.x
The effect of glycation on the structure, function and biological fate of human serum albumin as revealed by recombinant mutants
Biochimica et Biophysica Acta (BBA) - General Subjects · 2003 · 10.1016/j.bbagen.2003.08.001
Role of blood–brain barrier organic anion transporter 3 (OAT3) in the efflux of indoxyl sulfate, a uremic toxin: its involvement in neurotransmitter metabolite clearance from the brain
Journal of Neurochemistry · 2002 · 10.1046/j.1471-4159.2002.01108.x
Practical Aspects of the Ligand-Binding and Enzymatic Properties of Human Serum Albumin.
Biological and Pharmaceutical Bulletin · 2002 · https://doi.org/10.1248/bpb.25.695
Pharmaceutical Strategies Utilizing Recombinant Human Serum Albumin
Pharmaceutical Research · 2002 · 10.1023/a:1015396825274
Role of Arg-410 and Tyr-411 in human serum albumin for ligand binding and esterase-like activity
Biochemical Journal · 2000 · 10.1042/bj3490813
Nitrosothiol Formation Catalyzed by Ceruloplasmin
Journal of Biological Chemistry · 1999 · 10.1074/jbc.274.38.27069
Species Differences of Serum Albumins: I. Drug Binding Sites
Pharmaceutical Research · 1997 · 10.1023/a:1012138604016
Characterization of site I on human serum albumin: concept about the structure of a drug binding site
Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · 1996 · 10.1016/0167-4838(96)00013-1
Study of interaction of carprofen and its enantiomers with human serum albumin—I
Biochemical Pharmacology · 1993 · 10.1016/0006-2952(93)90576-i
Controlled release of indomethacin by chitosan-polyelectrolyte complex: optimization and in vivo/in vitro evaluation
Journal of Controlled Release · 1993 · 10.1016/0168-3659(93)90080-o
Controlled release of indomethacin by chitosan-polyelectrolyte complex: optimization and in vivo/in vitro evaluation
Journal of Controlled Release · 1993 · 10.1016/0168-3659(93)90080-o
Cyclodextrins in drug carrier systems.
PubMed · 1987
Cyclodextrin-induced hemolysis and shape changes of human erythrocytes in vitro.
Journal of Pharmacobio-Dynamics · 1982 · 10.1248/bpb1978.5.741
Inclusi on complexations of steroid hormones with cyclodextrins in water and in solid phase
International Journal of Pharmaceutics · 1982 · 10.1016/0378-5173(82)90057-6
Cyclodextrin-induced hemolysis and shape changes of human erythrocytes in vitro.
Journal of Pharmacobio-Dynamics · 1982 · 10.1248/bpb1978.5.741
The effect of albumin conformation on the binding of warfarin to human serum albumin. The dependence of the binding of warfarin to human serum albumin on the hydrogen, calcium, and chloride ion concentrations as studied by circular dichroism, fluorescence, and equilibrium dialysis.
Journal of Biological Chemistry · 1980 · 10.1016/s0021-9258(19)85847-7
Current projects
No projects listed.